Today: 2 July 2026
Robinhood stock jumps on Wolfe upgrade as HOOD heads into earnings
9 February 2026
1 min read

Robinhood stock jumps on Wolfe upgrade as HOOD heads into earnings

New York, February 9, 2026, 11:00 EST — Regular session

  • Robinhood stock climbed roughly 5.7% to $87.51 earlier in the session.
  • Wolfe Research bumped HOOD up to Outperform, assigning a $125 price target.
  • Bitcoin slid roughly 2%, and now investors are eyeing Tuesday’s results.

Robinhood Markets got a lift Monday, climbing roughly 5.7% to $87.51 after Wolfe Research boosted its rating on the online broker. Coinbase shares, by comparison, barely budged. Bitcoin, meanwhile, was lower.

The analyst call comes just one day ahead of Robinhood’s quarterly results, bringing fresh scrutiny to the company’s ability to sustain growth now that crypto trading has lost some heat and retail activity is settling down.

That’s relevant: Robinhood has acted as a high-octane play on risk-taking. A solid report might help shore up sentiment ahead of a busy week in markets, but a disappointment could bite.

Steven Chubak at Wolfe Research bumped Robinhood up to “Outperform” from “Peerperform” and slapped a $125 price target on the stock. Chubak said the firm plans to “take advantage of the recent selloff and deterioration in sentiment surrounding the broader crypto ecosystem.” Investing.com South Africa

Wolfe, in a separate note cited by The Fly, argued the recent slide sharpened the stock’s risk-reward, highlighting what it called a “durable” boost to earnings power. The firm also pointed to prediction-markets volumes as a buffer, should crypto conditions stay weak. TipRanks

Robinhood is sharpening its focus on prediction markets, rolling out sports-based event contracts—payouts hinging on specific outcomes. “There are a plethora of competitors. But with us being early to market, we’ve been able to fine-tune our product,” said Adam Hickerson, Robinhood’s senior director of futures, speaking to Reuters in December. Reuters

Truist Securities’ David Smith went the other way, trimming his target on HOOD to $130 from $155, though he stuck with a buy, according to TipRanks. Smith pointed to HOOD’s slide alongside weaker crypto prices, rather than fundamentals. Over at TipRanks, consensus points to EPS of $0.63 on $1.35 billion in revenue. Options figures signal traders are positioning for a move of around 12% after the numbers drop.

Investors are likely to dig into details beyond the main figures, with a close look at trading volumes for options and crypto, shifts in customer engagement, and whether net interest income from client cash balances shows any movement.

Robinhood’s move into event contracts isn’t without legal jeopardy, as questions loom over which lines regulators and courts will draw between state gambling statutes and federal oversight of derivatives. Friday, a Massachusetts judge ordered prediction-market operator Kalshi to halt sports-events contracts in the state within 30 days unless it secures a gaming license from Massachusetts.

Robinhood reports after markets close on Tuesday, with CEO Vlad Tenev and incoming CFO Shiv Verma set for a video call at 5 p.m. ET. Shareholders have until 5 p.m. ET Monday to submit or upvote questions, according to the company.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Gilead Sciences (GILD) Up 10% This Month; Zacks Rates It Buy on Earnings Outlook
    July 2, 2026, 10:41 AM EDT. Gilead Sciences (GILD) has climbed 10.3% in the last month, beating the S&P 500's 7.4% drop and a 1.6% gain for its medical-biomedical peers. Wall Street is looking for a 231.1% jump in current quarter EPS to $1.73, even after a 5% pullback in the consensus estimate over 30 days. For the full year, EPS is expected at $7.87, up 70.4%, with the forecast recently moved 3.7% higher. The outlook for next year went up 4.3% to $8.27. Zacks has Gilead at Rank #2 (Buy), pointing to earnings estimate momentum as a reason for potential near-term strength. Revenue growth stays important to hold up earnings.
Confluent stock edges higher as IBM deal vote nears after fresh merger filing
Previous Story

Confluent stock edges higher as IBM deal vote nears after fresh merger filing

Wells Fargo & Company stock drops 2% as CFO talks loan growth — what traders watch next
Next Story

Wells Fargo & Company stock drops 2% as CFO talks loan growth — what traders watch next

Go toTop